Bioventix Competitors and Similar CompaniesClear all
Bioventix's competitors and similar companies include Pacific Edge.
 Bioventix Bioventix is a biotechnology company specializing in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drug of abuse testing. | ||
Founding Date | Founding Date 2003 | Founding Date 2001 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Farnham, GB HQ | Locations Dunedin, NZ HQ Singapore, SG |
Employees | Employees 17 | Employees 114 |
Financial | ||
Revenue (est.) | Revenue (est.) £13.1m (FY, 2025) | Revenue (est.) $11.5m (FY, 2026) |
Cost of goods | Cost of goods £1.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit £12m (FY, 2025) | Gross profit $13m (FY, 2026) |
Net income | Net income £7.6m (FY, 2025) | Net income ($35.8m) (FY, 2026) |
For sources of this data, please see the company profile